Scribe Therapeutics Inc Common Stock

Scribe Therapeutics Inc Common Stock

Price & Volume

Stats

See more
52W Range
$15-$26.50
Market Cap
$420.7M
Shares Short
0

Financials

See more
Revenue (12 Mos)
$36.2M
Revenue Growth (YoY)
-87%
Gross Profit (12 Mos)
-$19.8M
Diluted EPS
-$2.03

About

CEO
Dr. Benjamin L. Oakes Ph.D.
CFO
Mr. David L. Parrot M.B.A.
Address
1150 Marina Village Pkwy, Alameda, CA, United States, 94501
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
89